1007 related articles for article (PubMed ID: 18520178)
1. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
[TBL] [Abstract][Full Text] [Related]
2. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
Ito Y; Takahashi Y; Fujita T; Fukuyama S
Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
[TBL] [Abstract][Full Text] [Related]
3. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].
Ohashi Y
Arerugi; 2008 May; 57(5):519-23. PubMed ID: 18520172
[No Abstract] [Full Text] [Related]
5. Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study.
Horiguchi S; Tanaka Y; Uchida T; Chazono H; Ookawa T; Sakurai D; Okamoto Y
Clin Exp Allergy; 2008 Mar; 38(3):405-12. PubMed ID: 18070160
[TBL] [Abstract][Full Text] [Related]
6. [A MULTICENTER CLINICAL SURVEY ABOUT THE PREVALENCE OF JAPANESE CYPRESS POLLINOSIS AND THE EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH JAPANESE CEDAR POLLEN EXTRACT DURING JAPANESE CYPRESS POLLEN DISPERSAL PERIOD].
Oka A; Yuta A; Okawa Y; Masuno S; Tsunoda T; Takahara E; Terada A; Kanai K; Nagakura H; Mimura H; Arao H; Ueyama S; Ueyama A; Tokuda R; Bamba H; Nakazato H; Nakazato M; Amesara R; Nakai S; Araki S; Sakaida M; Tokuriki M; Hama T; Chiba M; Ikeda H; Togawa A; Tsuzuki H; Hyo Y; Niitsu S; Ohkawa C; Nakamoto S; Takeo T; Kumanomidou H; Kanai K; Kitamura H; Sugiura R; Okano M
Arerugi; 2023; 72(9):1138-1146. PubMed ID: 37967960
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
8. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
[TBL] [Abstract][Full Text] [Related]
9. Present situation of cedar pollinosis in Japan and its immune responses.
Okamoto Y; Horiguchi S; Yamamoto H; Yonekura S; Hanazawa T
Allergol Int; 2009 Jun; 58(2):155-62. PubMed ID: 19307773
[TBL] [Abstract][Full Text] [Related]
10. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
[TBL] [Abstract][Full Text] [Related]
11. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
Allergol Int; 2009 Jun; 58(2):237-45. PubMed ID: 19307778
[TBL] [Abstract][Full Text] [Related]
12. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH CEDAR POLLEN IN A YEAR OF MASSIVE CEDAR POLLEN DISPERSAL AND ITS EFFECT ON JAPANESE CYPRESS POLLINOSIS].
Yuta A; Ogawa Y; Kozaki H; Shimizu T
Arerugi; 2023; 72(10):1230-1239. PubMed ID: 38092399
[TBL] [Abstract][Full Text] [Related]
13. Sublingual immunotherapy for Japanese cedar pollinosis.
Okubo K; Gotoh M
Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
[TBL] [Abstract][Full Text] [Related]
14. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940
[TBL] [Abstract][Full Text] [Related]
15. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
Osada T; Tanaka Y; Yamada A; Sasaki E; Utsugi T
Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489
[TBL] [Abstract][Full Text] [Related]
16. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis.
Kikuoka H; Kouzaki H; Matsumoto K; Arai H; Yamamoto S; Tojima I; Shimizu S; Miyashita H; Ogawa Y; Osada T; Okano M; Yuta A; Shimizu T
Clin Immunol; 2020 Jan; 210():108310. PubMed ID: 31743749
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
[TBL] [Abstract][Full Text] [Related]
18. Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment.
Osada T; Okano M
Allergol Int; 2021 Jul; 70(3):281-290. PubMed ID: 33962864
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of Juniperus ashei sublingual-swallow ultra-rush pollen immunotherapy in cypress rhinoconjunctivitis. A double-blind, placebo-controlled study.
Vervloet D; Birnbaum J; Laurent P; Hugues B; Fardeau MF; Massabie-Bouchat YP; Aferiat-Derome A; André C
Int Arch Allergy Immunol; 2007; 142(3):239-46. PubMed ID: 17114889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
